SG&A Expense (TTM) Chart

Historical SG&A Expense (TTM) Data

View and export this data back to 2001. Start Trial.
Date Value
June 30, 2026 656.52M
March 31, 2026 663.72M
December 31, 2025 593.02M
September 30, 2025 599.83M
June 30, 2025 610.92M
March 31, 2025 605.38M
December 31, 2024 632.49M
September 30, 2024 659.03M
June 30, 2024 672.75M
March 31, 2024 725.48M
December 31, 2023 756.24M
September 30, 2023 789.92M
June 30, 2023 841.94M
March 31, 2023 884.60M
December 31, 2022 936.58M
September 30, 2022 956.11M
June 30, 2022 914.62M
March 31, 2022 826.82M
December 31, 2021 730.45M
September 30, 2021 646.98M
June 30, 2021 584.29M
March 31, 2021 564.72M
December 31, 2020 549.75M
September 30, 2020 527.70M
June 30, 2020 549.67M
Date Value
March 31, 2020 534.27M
December 31, 2019 508.03M
September 30, 2019 485.70M
June 30, 2019 473.71M
March 31, 2019 467.58M
December 31, 2018 452.32M
September 30, 2018 441.86M
June 30, 2018 421.23M
March 31, 2018 402.36M
December 31, 2017 399.70M
September 30, 2017 400.44M
June 30, 2017 399.85M
March 31, 2017 402.72M
December 31, 2016 398.47M
September 30, 2016 387.51M
June 30, 2016 370.62M
March 31, 2016 345.80M
December 31, 2015 319.53M
September 30, 2015 291.04M
June 30, 2015 268.27M
March 31, 2015 249.11M
December 31, 2014 232.22M
September 30, 2014 225.02M
June 30, 2014 220.31M
March 31, 2014 219.29M

SG&A Expense (TTM) Range, Past 5 Years

View SG&A Expense (TTM) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

SG&A Expense (TTM) Benchmarks

View SG&A Expense (TTM) Benchmarks
Start Trial
InfuSystem Holdings, Inc. 68.27M
Circle8 Group, Inc. 71.89M
Centene Corp. 0.00
Cardinal Health, Inc. 6.132B
OPKO Health, Inc. 205.85M